Upregulation of miR-196b confers a poor prognosis in glioblastoma patients via inducing a proliferative phenotype.
about
MicroRNAs in glioblastoma multiforme pathogenesis and therapeuticsmiR-196, an Emerging Cancer Biomarker for Digestive Tract CancersAn eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinomaSignificance of miR-196b in tumor-related epilepsy of patients with gliomas.Combined elevation of microRNA-196a and microRNA-196b in sera predicts unfavorable prognosis in patients with osteosarcomas.MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview.Upregulation of microRNA-196a and microRNA-196b cooperatively correlate with aggressive progression and unfavorable prognosis in patients with colorectal cancerEstimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signaturesThe transcriptome and miRNome profiling of glioblastoma tissues and peritumoral regions highlights molecular pathways shared by tumors and surrounding areas and reveals differences between short-term and long-term survivors.miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.Dysregulated miR-671-5p / CDR1-AS / CDR1 / VSNL1 axis is involved in glioblastoma multiforme.Aberrant DNA hypomethylation of miR-196b contributes to migration and invasion of oral cancer.Nucleolin-aptamer therapy in retinoblastoma: molecular changes and mass spectrometry-based imagingMiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IκBα both in vitro and in vivo.Current progress for the use of miRNAs in glioblastoma treatment.Molecular prognostic factors in glioblastoma: state of the art and future challenges.MicroRNA as potential biomarkers in Glioblastoma.MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer.miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma.Involvement of microRNAs in epileptogenesis.miR-211 promotes non-small cell lung cancer proliferation by targeting SRCIN1.The diagnostic effect of serum miR-196b as biomarker in colorectal cancerMiR-139 inhibits Mcl-1 expression and potentiates TMZ-induced apoptosis in glioma.miR-506 inhibits the proliferation and invasion by targeting IGF2BP1 in glioblastoma.Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.Clinical implications of microRNAs in human glioblastomaRisk Score based on microRNA expression signature is independent prognostic classifier of glioblastoma patients.MicroRNA‑376a inhibits cell proliferation and invasion in glioblastoma multiforme by directly targeting specificity protein 1.Homeobox A9 directly targeted by miR-196b regulates aggressiveness through nuclear Factor-kappa B activity in non-small cell lung cancer cells.
P2860
Q26747273-A420B45D-889C-4EC6-A813-26D7D5C3BCD0Q26748577-2D18BA70-3177-4B51-81C6-DAEE69A6A052Q28388180-D4F68266-790E-49E7-A52C-27B8BC75FB34Q31104534-61260E94-CAD3-4AD3-84F2-3B900E22A9D3Q33580714-F25C5690-8A57-49F7-9323-6A96EE8B7596Q34409620-2FAA4829-5492-4AEA-B581-6BCF473694A3Q34727926-7EF87312-C6FC-459C-ACEE-3264C4306477Q36268697-518E9FA2-FD81-4DBB-9A58-320F4FBEA979Q36356011-CE75925F-38E8-41A5-B6F1-BF90101AEF3DQ36557234-54A7867A-EECF-4F53-B2FE-3D3386F7B67AQ36782575-17358623-FC23-4E00-B10F-F47C05202FF8Q36954303-9F673832-E03F-459B-88DA-8CEC54A9F49CQ37256221-B314486F-8994-4062-A31D-E0F429FC58D7Q37699427-DC64B221-C8FC-4F12-BA2A-A3A25FC56C10Q38102611-F7FC6115-9D7D-4272-A2F6-FE841B9CAA3CQ38233134-C1957F2B-460A-49F0-8995-309D308BACFFQ38590626-D4E71DA3-FAC6-4886-BC09-71F2E73B5978Q38716962-103F2CBC-12B9-4CF8-9F42-6E37D385594BQ38804354-46F433D4-9017-4461-B749-4091DCED8E0DQ38840417-26EBD621-5BE2-4112-A813-17BC71ADC6A1Q38843399-914E3465-5090-4624-87CA-88FEBDE8963BQ38998550-6006F4C2-588C-4935-9573-6F8BBBB85D20Q39172188-BC010BD8-32A1-4107-AD17-F66AAD935DDFQ40182494-BFA578F3-1876-420B-B915-1FF7290FFC18Q41820502-9DEF23DF-566C-4F20-8519-7AFE925ECF76Q41872498-E1698430-4A6C-4D6B-8DDA-A44DCEF65542Q44744230-0813F4AB-4E89-4959-A54C-5AE68BA518E3Q47276495-C3470BC3-9178-425A-A673-DD4CAF71E33EQ53184876-DD91D338-2617-44FD-B2B3-FE2513D5F8D5
P2860
Upregulation of miR-196b confers a poor prognosis in glioblastoma patients via inducing a proliferative phenotype.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Upregulation of miR-196b confe ...... ing a proliferative phenotype.
@ast
Upregulation of miR-196b confe ...... ing a proliferative phenotype.
@en
Upregulation of miR-196b confe ...... ing a proliferative phenotype.
@nl
type
label
Upregulation of miR-196b confe ...... ing a proliferative phenotype.
@ast
Upregulation of miR-196b confe ...... ing a proliferative phenotype.
@en
Upregulation of miR-196b confe ...... ing a proliferative phenotype.
@nl
prefLabel
Upregulation of miR-196b confe ...... ing a proliferative phenotype.
@ast
Upregulation of miR-196b confe ...... ing a proliferative phenotype.
@en
Upregulation of miR-196b confe ...... ing a proliferative phenotype.
@nl
P2093
P2860
P1433
P1476
Upregulation of miR-196b confe ...... ing a proliferative phenotype.
@en
P2093
Guojun Zhang
Junxia Zhang
Xixiong Kang
P2860
P304
P356
10.1371/JOURNAL.PONE.0038096
P407
P577
2012-06-19T00:00:00Z